Literature DB >> 9339932

Adult-to-adult living donor liver transplantation using extended right lobe grafts.

C M Lo1, S T Fan, C L Liu, W I Wei, R J Lo, C L Lai, J K Chan, I O Ng, A Fung, J Wong.   

Abstract

OBJECTIVE: The authors report their experience with living donor liver transplantation (LDLT) using extended right lobe grafts for adult patients under high-urgency situations. SUMMARY BACKGROUND DATA: The efficacy of LDLT in the treatment of children has been established. The major limitation of adult-to-adult LDLT is the adequacy of the graft size. A left lobe graft from a relatively small volunteer donor will not meet the metabolic demand of a larger recipient.
METHODS: From May 1996 to November 1996, seven LDLTs, using extended right lobe grafts, were performed under high-urgency situations. All recipients were in intensive care units before transplantation with five having acute renal failure, three on mechanical ventilation, and all with hepatic encephalopathy. The median body weight for the donors and recipients was 58 kg (range, 41-84 kg) and 65 kg (range, 53-90 kg), respectively. The body weights of four donors were less than those of the corresponding recipients, and the lowest donor-to-recipient body weight ratio was 0.62:1. The extended right lobe graft was chosen because the left lobe volume was <40% of the ideal liver mass of the recipient.
RESULTS: Median blood loss for the donors was 900 mL (range, 700-1600 mL) and hospital stay was 19 days (range, 8-22 days). Homologous blood transfusion was not required. Two donors had complications (one incisional hernia and one bile duct stricture) requiring reoperation after discharge. All were well with normal liver function 5 to 10 months after surgery. The graft weight ranged from 490 g to 1140 g. All grafts showed immediate function with normalization of prothrombin time and recovery of conscious state of the recipients. There was no vascular complication, but six recipients required reoperation. One recipient died of systemic candidiasis 16 days after transplantation and 6 (86%) were alive with the original graft at a median follow-up of 6.5 months (range, 5-10 months).
CONCLUSIONS: When performed by a team with experience in hepatectomy and transplantation, LDLT, using an extended right lobe graft, can achieve superior results. The technique extends the success of LDLT from pediatric recipients to adult recipients and opens a new donor pool for adults to receive a timely graft of adequate function.

Entities:  

Mesh:

Year:  1997        PMID: 9339932      PMCID: PMC1191019          DOI: 10.1097/00000658-199709000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  30 in total

1.  Living unrelated liver transplantation between spouses for fulminant hepatic failure.

Authors:  C M Lo; P Gertsch; S T Fan
Journal:  Br J Surg       Date:  1995-08       Impact factor: 6.939

2.  Living-related liver transplantation in adult recipients: a hypothesis.

Authors:  N Habib; K Tanaka
Journal:  Clin Transplant       Date:  1995-02       Impact factor: 2.863

3.  Timing of transplantation and donor selection in living related liver transplantation for fulminant Wilson's disease.

Authors:  H Terajima; K Tanaka; K Okajima; Y Inomata; Y Yamaoka
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

4.  Living related liver transplantation: 36 cases at the University of Hamburg.

Authors:  M Malagó; X Rogiers; M Burdelski; C E Broelsch
Journal:  Transplant Proc       Date:  1994-12       Impact factor: 1.066

5.  Anterior approach for difficult major right hepatectomy.

Authors:  E C Lai; S T Fan; C M Lo; K M Chu; C L Liu
Journal:  World J Surg       Date:  1996 Mar-Apr       Impact factor: 3.352

Review 6.  In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool.

Authors:  X Rogiers; M Malagó; K Gawad; K W Jauch; M Olausson; W T Knoefel; M Gundlach; A Bassas; L Fischer; M Sterneck; M Burdelski; C E Broelsch
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

7.  Safety of the donor in living-related liver transplantation--an analysis of 100 parental donors.

Authors:  Y Yamaoka; T Morimoto; T Inamoto; A Tanaka; K Honda; I Ikai; K Tanaka; M Ichimiya; M Ueda; Y Shimahara
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

8.  Auxiliary liver transplantation for fulminant and subfulminant hepatic failure.

Authors:  K Boudjema; D Cherqui; D Jaeck; M P Chenard-Neu; A Steib; G Freis; F Becmeur; B Brunot; U Simeoni; J P Bellocq
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

9.  Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience.

Authors:  H Bismuth; D Samuel; D Castaing; R Adam; F Saliba; M Johann; D Azoulay; B Ducot; L Chiche
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

10.  Living donor for liver transplantation.

Authors:  C E Broelsch; M Burdelski; X Rogiers; M Gundlach; W T Knoefel; T Langwieler; L Fischer; A Latta; H Hellwege; F J Schulte
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

View more
  80 in total

1.  Small bile duct reconstruction of the caudate lobe in living-related liver transplantation.

Authors:  Keiichi Kubota; Tadatoshi Takayama; Keiji Sano; Kiyoshi Hasegawa; Taku Aoki; Yasuhiko Sugawara; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

2.  [Living donor liver transplantation].

Authors:  K Tanaka; S Kaihara
Journal:  Chirurg       Date:  2003-10       Impact factor: 0.955

3.  Cantlie's plane in major variations of the primary portal vein ramification at the porta hepatis: cutting experiment using cadaveric livers.

Authors:  Saiho Ko; Gen Murakami; Tetsuhiro Kanamura; Toshio J Sato; Yoshiyuki Nakajima
Journal:  World J Surg       Date:  2003-11-26       Impact factor: 3.352

4.  Computer-aided measurement of liver volumes in CT by means of geodesic active contour segmentation coupled with level-set algorithms.

Authors:  Kenji Suzuki; Ryan Kohlbrenner; Mark L Epstein; Ademola M Obajuluwa; Jianwu Xu; Masatoshi Hori
Journal:  Med Phys       Date:  2010-05       Impact factor: 4.071

5.  Living donor right liver lobe transplantation with or without inclusion of the middle hepatic vein: analysis of complications.

Authors:  Jorge Marcelo Padilla Mancero; Adriano Miziara Gonzalez; Marcelo Augusto Fontenelle Ribeiro; Gilberto Peron; Raul Carlos Wahle; Francisco Leôncio Dazzi; Adávio de Oliveira e Silva; Luiz Augusto Carneiro D'Albuquerque
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

6.  Surgical anatomy of the bile ducts at the hepatic hilum as applied to living donor liver transplantation.

Authors:  Masayuki Ohkubo; Masato Nagino; Junichi Kamiya; Norihiro Yuasa; Koji Oda; Toshiyuki Arai; Hideki Nishio; Yuji Nimura
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

7.  Adult-to-adult living donor liver transplantation for acute liver failure in China.

Authors:  Ding Yuan; Fei Liu; Yong-Gang Wei; Bo Li; Lv-Nan Yan; Tian-Fu Wen; Ji-Chun Zhao; Yong Zeng; Ke-Fei Chen
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

8.  Safety and necessity of including the middle hepatic vein in the right lobe graft in adult-to-adult live donor liver transplantation.

Authors:  Sheung-Tat Fan; Chung-Mau Lo; Chi-Leung Liu; Wen-Xi Wang; John Wong
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

9.  Preliminary experience in adult-to-adult living donor liver transplantation in a single center in China.

Authors:  Lunan Yan; Bo Li; Yong Zeng; Tianfu Wen; Jichun Zhao; Wentao Wang; Jiayin Yang; Mingqing Xu; Yukui Ma; Zheyu Chen; Jiangwen Liu; Hong Wu
Journal:  Front Med China       Date:  2007-02-01

Review 10.  Current concept of small-for-size grafts in living donor liver transplantation.

Authors:  Toru Ikegami; Mitsuo Shimada; Satoru Imura; Yusuke Arakawa; Akira Nii; Yuji Morine; Hirofumi Kanemura
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.